Common variants of cytochrome P450 4F2 exhibit altered vitamin E-ω-hydroxylase specific activity

Journal of Nutrition

Volumn 140, Issue 11, 2010, Pages 1901-1906

  Bardowell, Sabrina A ^a   Stec, David E ^b   Parker, Robert S ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKANE 1 MONOOXYGENASE; ALPHA TOCOPHEROL; CYTOCHROME P450; CYTOCHROME P450 4F2; UNCLASSIFIED DRUG; 20 HYDROXY 5,8,11,14 EICOSATETRAENOIC ACID; 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; ALPHA TOCOTRIENOL; ARACHIDONIC ACID; CYP4F2 PROTEIN, HUMAN; HYDROXYICOSATETRAENOIC ACID; RECOMBINANT PROTEIN; TOCOPHEROL;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME SPECIFICITY; ENZYME SUBSTRATE; GENE; GENE MUTATION; GENETIC VARIABILITY; INSECT CELL; MICROSOME; NONHUMAN; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE; CHEMISTRY; GENETIC ASSOCIATION; GENETICS; HUMAN; HYDROXYLATION; KINETICS; MASS FRAGMENTOGRAPHY; METABOLISM;

HEXAPODA;

ALPHA-TOCOPHEROL; ARACHIDONIC ACID; CYTOCHROME P-450 ENZYME SYSTEM; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GENETIC ASSOCIATION STUDIES; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; HYDROXYLATION; KINETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; TOCOPHEROLS; TOCOTRIENOLS; VITAMIN E;

EID: 78149233277     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.110.128579     Document Type: Article

References (26)

1. Sontag TJ, Parker RS. Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J Biol Chem. 2002;277:25290-6.
2. Parker RS, Sontag TJ, Swanson JE, McCormick CC. Discovery, characterization, and significance of the cytochrome P450 omega-hydroxylase pathway of vitamin E catabolism. Ann N Y Acad Sci. 2004;1031:13-21.
3. Kikuta Y, Kusunose E, Kondo T, Yamamoto S, Kinoshita H, Kusunose M. Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. FEBS Lett. 1994;348:70-4. (Pubitemid 24223036)
4. Powell PK, Wolf I, Jin R, Lasker JM. Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11. J Pharmacol Exp Ther. 1998;285:1327-36.
5. Schonfeld A, Schultz M, Petrizka M, Gassmann B. A novel metabolite of RRR-alpha-tocopherol in human urine. Nahrung. 1993;37:498-500.
6. Wechter WJ, Kantoci D, Murray ED Jr, D'Amico DC, Jung ME, Wang WH. A new endogenous natriuretic factor: LLU-alpha. Proc Natl Acad Sci USA. 1996;93:6002-7. (Pubitemid 26190792)
7. Swanson JE, Ben RN, Burton GW, Parker RS. Urinary excretion of 2,7, 8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman is a major route of elimination of gamma-tocopherol in humans. J Lipid Res. 1999;40:665-71.
8. Sontag TJ, Parker RS. Influence of major structural features of tocopherols and tocotrienols on their omega-oxidation by tocopherol-omega- hydroxylase. J Lipid Res. 2007;48:1090-8.
9. Traber MG, Sokol RJ, Burton GW, Ingold KU, Papas AM, Huffaker JE, Kayden HJ. Impaired ability of patients with familial isolated vitamin E deficiency to incorporate alpha-tocopherol into lipoproteins secreted by the liver. J Clin Invest. 1990;85:397-407.
10. Kelly FJ, Lee R, Mudway IS. Inter- and intra-individual vitamin E uptake in healthy subjects is highly repeatable across a wide supplementation dose range. Ann N Y Acad Sci. 2004;1031:22-39.
11. Doring F, Rimbach G, Lodge JK. In silico search for single nucleotide polymorphisms in genes important in vitamin E homeostasis. IUBMB Life. 2004;56:615-20.
12. Stec DE, Roman RJ, Flasch A, Rieder MJ. Functional polymorphism in human CYP4F2 decreases 20-HETE production. Physiol Genomics. 2007;30:74-81.
13. Caldwell MD, Awad T, Johnson JA, Gage BF, Falkowski M, Gardina P, Hubbard J, Turpaz Y, Langaee TY, et al. CYP4F2 genetic variant alters required warfarin dose. Blood. 2008;111:4106-12.
14. Fava C, Montagnana M, Almgren P, Rosberg L, Lippi G, Hedblad B, Engstrom G, Berglund G, Minuz P, et al. The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure. Hypertension. 2008;52:373-80.
15. Deng S, Zhu G, Liu F, Zhang H, Qin X, Li L, Zhiyi H. CYP4F2 gene V433M polymorphism is associated with ischemic stroke in the male Northern Chinese Han population. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:664-8.
16. Ding H, Cui G, Zhang L, Xu Y, Bao X, Tu Y, Wu B, Wang Q, Hui R, et al. Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population. Pharmacogenet Genomics. 2010;20:187-94.
17. McDonald MG, Rieder MJ, Nakano M, Hsia CK, Rettie AE. CYP4F2 is a vitamin K1 oxidase: an explanation for altered warfarin dose in carriers of the V433M variant. Mol Pharmacol. 2009;75:1337-46.
18. Jiang Q, Lykkesfeldt J, Shigenaga MK, Shigeno ET, Christen S, Ames BN. Gamma-tocopherol supplementation inhibits protein nitration and ascorbate oxidation in rats with inflammation. Free Radic Biol Med. 2002;33:1534-42.
19. Jiang Q, Ames BN. gamma-Tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB J. 2003;17:816-22. (Pubitemid 36538656)
20. Khanna S, Roy S, Slivka A, Craft TK, Chaki S, Rink C, Notestine MA, DeVries AC, Parinandi NL, et al. Neuroprotective properties of the natural vitamin E alpha-tocotrienol. Stroke. 2005;36:2258-64.
21. McCormick CC, Parker RS. The cytotoxicity of vitamin E is both vitamer- and cell-specific and involves a selectable trait. J Nutr. 2004;134:3335-42.
22. Christmas P, Jones JP, Patten CJ, Rock DA, Zheng Y, Cheng SM, Weber BM, Carlesso N, Scadden DT, et al. Alternative splicing determines the function of CYP4F3 by switching substrate specificity. J Biol Chem. 2001;276:38166-72.
23. Grau A, Ortiz A. Dissimilar protection of tocopherol isomers against membrane hydrolysis by phospholipase A2. Chem Phys Lipids. 1998;91:109-18. (Pubitemid 28142958)
24. Yamashita K, Iizuka Y, Imai T, Namiki M. Sesame seed and its lignans produce marked enhancement of vitamin E activity in rats fed a low alpha-tocopherol diet. Lipids. 1995;30:1019-28.
25. Parker RS, Sontag TJ, Swanson JE. Cytochrome P4503A-dependent metabolism of tocopherols and inhibition by sesamin. Biochem Biophys Res Commun. 2000;277:531-4.
26. Cooney RV, Custer LJ, Okinaka L, Franke AA. Effects of dietary sesame seeds on plasma tocopherol levels. Nutr Cancer. 2001;39:66-71.